Pharming Group N.V. Noncurrent Restricted Cash And Cash Equivalents
Pharming Group N.V. (PHAR) had Noncurrent Restricted Cash And Cash Equivalents of $1.23 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:NoncurrentRestrictedCashAndCashEquivalents · last filed 2026-04-02
- 2020-12-31: Noncurrent Restricted Cash And Cash Equivalents 415.00K EUR.
- 2019-12-31: Noncurrent Restricted Cash And Cash Equivalents 2.27M EUR.
EUR
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2020-12-31 | 415.00K EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 2.27M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Noncurrent Restricted Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $1.23M 20-F · filed 2026-04-02 |
| 2024-12-31 | $1.50M 20-F · filed 2026-04-02 |
| 2023-12-31 | $1.53M 20-F · filed 2025-04-03 |
| 2022-12-31 | $1.10M 20-F · filed 2024-04-04 |
| 2021-12-31 | $812.00K 20-F · filed 2023-04-05 |
| 2020-12-31 | $510.00K 20-F · filed 2022-04-06 |
| 2019-12-31 | $2.54M 20-F · filed 2022-04-06 |